Evidence-driven support for product claims—covering nutrient content, structure/function, health, and cosmetic assertions. We ensure each label statement is backed by competent, reliable scientific studies and meets global regulatory requirements.
Need Expert Help? We’re Just a Call Away.
Build consumer trust with scientifically validated claims.
At BioAgile Therapeutics, we provide robust evidence to substantiate your product claims, ensuring compliance with FDA, EMA, and CDSCO regulations.
Our services help you meet legal requirements while promoting ethical marketing practices, transforming scientific rigor into credible consumer confidence.
What is Label Claims Substantiation? Definition and Importance
Label claims substantiation is the process of providing solid scientific evidence to support the benefit statements made on your product labels.
Unlike general marketing language, substantiated claims are backed by objective, measurable data, ensuring your communication is accurate and trustworthy.
This process is not just a regulatory requirement, it also protects consumers and strengthens your brand’s reputation.
In India, FSSAI’s new ‘scientific dossier approval’ system, effective from January 1, 2026, makes substantiation a mandatory step for all food and nutraceutical products.
At BioAgile, we guide you through this process, turning scientific rigor into consumer confidence.
What is Label Claims: Types and Regulatory Classifications
Label claims communicate the benefits or effects of a product to consumers.
They must be accurate, truthful, and supported by scientific evidence.
Broadly, label claims can be classified into three main types:
- Nutritional Claims – Statements about the nutritional content of a product
- Health Claims – Claims linking a product to specific health benefits
- Functional Claims – Statements describing a product’s role in maintaining or supporting normal physiological functions
Regulatory authorities across different regions have set clear guidelines for each type of claim.
In India, FSSAI mandates that health and functional claims must be backed by a scientific dossier, effective January 1, 2026.
Similarly, FDA and EMA require evidence-based substantiation for health-related statements.
Proper classification and substantiation of claims ensure legal compliance, protect consumers, and strengthen your brand’s credibility.
At BioAgile, we help you navigate these classifications and regulatory requirements with scientifically robust support.
Nutrient Function Claims and Structural Function Claims
Nutrient and structural function claims explain how a nutrient supports normal body functions.
For example, “Calcium helps in the normal development of bones.”
These claims usually require the nutrient to meet specific thresholds, such as a minimum percentage of the Nutrient Reference Value (NRV).
Health Claims and Disease Risk Reduction Claims
Health claims connect a food or nutrient to improved health or reduced disease risk.
Claims must never suggest treatment, cure, or prevention without regulatory approval.
In India, FSSAI allows disease risk reduction claims only under specific Schedule regulations.
Permissible wording includes phrases like “may help reduce risk,” while terms like “prevents” or “cures” are not allowed.
Other Functional Claims and Cosmetic/Medical Device Claims
Functional claims highlight specific benefits on body functions, such as “supports digestive health.”
Cosmetic claims focus on appearance or performance, like skin moisture, firmness, or hair shine.
Medical device claims describe product performance, for example, “provides compression support.”
The type of claim determines the required evidence and how it should be substantiated.
Randomized Controlled Trials (RCTs) as Gold Standard Evidence
Randomized Controlled Trials (RCTs) are the gold standard for proving health benefits.
Participants are randomly assigned to treatment or control/placebo groups, minimizing bias.
Key elements include double-blinding, adequate sample size, study duration, and validated outcome measures.
Regulatory bodies like FDA, FTC, and EMA recognize RCTs as definitive evidence, with Phase III trials often serving as the benchmark for approval and substantiation of claims.
Quality Hierarchy: Evidence Types and Validation
Evidence strength follows a clear hierarchy:
- Randomized controlled trials (highest)
- Case-control studies
- Single-arm and open-label studies
- Observational research
- In vitro studies (supportive, not standalone proof)
Claim Substantiation Across Product Categories
Product claims differ widely depending on the category, and each requires a tailored substantiation approach.
At BioAgile Therapeutics, we support claim validation across foods, nutraceuticals, cosmetics, medical devices, and pharmaceutical products, aligning scientific evidence with applicable regulatory expectations.
For foods and nutraceuticals, substantiation focuses on nutritional, functional, and health claims.
Evidence may include published literature, compositional analysis, human studies, or randomized controlled trials, depending on claim complexity.
With FSSAI’s scientific dossier approval system effective January 1, 2026, robust documentation and evidence-based justification are essential.
Cosmetic claims typically relate to appearance or performance, such as skin hydration, firmness, wrinkle reduction, or hair strength.
These claims are supported through a combination of instrumental testing, dermatological evaluations, consumer use studies, and, where appropriate, clinical trials—without implying medical benefits.
For medical devices, claims must demonstrate product performance, safety, and intended use.
Substantiation may include bench testing, usability studies, biocompatibility assessments, and clinical evaluations, depending on device classification and risk profile.
In the pharmaceutical category, claim substantiation is the most rigorous, relying on phased clinical trials to establish safety and efficacy.
Each phase contributes critical evidence to support regulatory approval and label statements.
By applying the right level of evidence for each product category, BioAgile ensures claims are scientifically sound, regulatory compliant, and trusted by both regulators and consumers.
Food, Nutraceutical, and Dietary Supplement Claim Substantiation
BioAgile Therapeutics supports claim substantiation through human clinical trials conducted in the target population, in line with regulatory requirements.
These studies generate objective and measurable evidence to support functional and health claims and form a critical component of the Claim Support Dossier (CSD).
Cosmetic and Cosmeceutical Claims Substantiation
Efficacy testing for cosmetic claims uses a combination of objective and consumer-focused methods.
Quantifiable claims are supported through instrumental testing such as TEWL meters, Vapometers, and Elastimeters.
“Dermatologically tested” claims are validated through clinical studies conducted under dermatologist supervision.
Subjective claims like “feels softer” or “adds luxurious shine” are supported by sensory and consumer perception studies.
Medical Device Performance Claims Substantiation
Clinical trials play a critical role in substantiating medical device performance claims.
These studies are designed to validate clinical utility and effectiveness, such as compression support, durability, or functional performance, under real-world use conditions.
The resulting clinical data supports regulatory submissions, including 510(k), by demonstrating that the device performs as intended and meets applicable regulatory expectations.
Pharmaceutical Product Claims and Drug Safety Substantiation
Pharmaceutical product claims require robust scientific evidence generated through phased clinical development.
Safety and efficacy are established through Phase I to Phase III clinical trials, supported by pharmacokinetic and pharmacodynamic (PK/PD) studies.
Clinical data is reviewed alongside CMC information to ensure product quality and consistency.
Adverse event monitoring is a critical part of these studies, and all claims must accurately reflect known risks as stated in the approved product label.
Building a Robust Claim Support Dossier (CSD): Structure and Components
A well-structured Claim Support Dossier (CSD) is essential for substantiating product claims and ensuring regulatory compliance.
At its core, a CSD compiles all evidence supporting the claims, including human clinical trial data, published scientific literature, and validated study results.
For foods, nutraceuticals, and dietary supplements, the dossier includes clinical trial protocols, study outcomes, and statistical analyses demonstrating the product’s functional or health benefits.
Cosmetic and medical device dossiers incorporate clinical studies evaluating efficacy, performance, and consumer perception.
Pharmaceutical dossiers include phased clinical trial data along with pharmacokinetic and pharmacodynamic assessments.
Each CSD clearly outlines study objectives, methodology, participant selection, endpoints, and results to provide regulators with transparent and verifiable evidence.
Essential Documentation Components of a CSD
A robust Claim Support Dossier (CSD) includes:
- Product specification with active ingredients and formulation details
- Exact claim statement to be validated
- Clinical trial data supporting safety and efficacy
- Literature reviews from peer-reviewed journals
- Systematic reviews and meta-analyses
- Summary document highlighting substantiation data and regulatory compliance
Regulatory Frameworks and Compliance Standards by Jurisdiction
Product claims must comply with the regulatory requirements of the target market, which vary across jurisdictions.
In India, FSSAI governs foods, nutraceuticals, and dietary supplements, requiring a scientific Claim Support Dossier (CSD) for functional and health claims, with mandatory dossier approval effective January 1, 2026.
Cosmetic claims are regulated under the Drugs & Cosmetics Act, while medical devices follow the Medical Device Rules.
In the United States, the FDA and FTC mandate that all claims be supported by “competent and reliable scientific evidence.”
In the European Union, EFSA and EMA require robust clinical or literature-based evidence.
Across all jurisdictions, regulatory compliance ensures claims are accurate, scientifically supported, and transparent.
FSSAI Regulations and India-Specific Requirements
In India, FSSAI regulates product claims to ensure they are accurate and safe for consumers.
Claims are classified by type and must meet standards for nutrient content and compliance with daily recommended allowances.
From 2026, all new products require scientific dossier approval.
Non-compliance can result in fines, reinforcing the importance of reliable and evidence-based claims.
Study Methodologies for Different Claim Types
Clinical Trial Designs for Efficacy and Performance Claims
Randomized, double-blind, placebo-controlled trials are the preferred methodology for substantiating efficacy and performance claims.
Primary endpoints assess the claimed benefit, while secondary endpoints evaluate safety and tolerability.
Sample size is determined through power analysis to ensure statistically significant results.
Instrumental Testing Methods
Instrumental testing provides objective, quantifiable evidence of product efficacy.
Devices include:
- Vapometer and Tewameter for skin moisture and barrier function
- Corneometer for skin hydration
- Elastimeter for skin elasticity and firmness
Consumer Perception and Home User Trial (HUT) Studies
Home User Trials (HUT) assess product performance in real-world settings.
Participants provide feedback on sensory attributes, satisfaction, perceived efficacy, and usage frequency.
HUTs support subjective claims but are not sufficient for objective health benefit substantiation.
Distinguishing Permissible and Prohibited Claims
Claims must accurately reflect evidence and avoid implying disease treatment or cure unless approved as a drug.
Permissible claims use measurable, substantiated language aligned with regulatory standards.
Clear differentiation protects brands from penalties and builds consumer trust.
Disease Prevention vs. Risk Reduction Language
Food products cannot claim to “prevent,” “treat,” or “cure” diseases.
Permitted wording includes risk reduction language such as “may help reduce the risk of.”
Unsubstantiated Superlatives and Vague Marketing Language
Unqualified claims like “100%” or vague terms such as “natural” require scientific evidence.
Non-compliance can lead to recalls or license suspension.
Quality Considerations in Evidence Assessment
High-quality evidence uses robust methodologies, appropriate controls, validated outcomes, and sufficient sample sizes.
Study design, statistical analysis, and transparency directly influence claim strength.
Study Population Relevance and Generalizability
Clinical evidence must match the intended consumer population.
Larger confirmatory trials provide stronger generalizability than small pilot studies.
Dose, Duration, and Bioavailability Considerations
Studies must use the same formulation, dose, and duration as the marketed product.
Bioavailability differences must be addressed to ensure relevance.
Statistical Significance vs. Clinical Meaningfulness
Claims should be supported by results that are both statistically significant and clinically meaningful.
Outdated or Low-Quality Evidence
Uncontrolled trials, testimonials, animal studies, or in vitro studies alone are insufficient.
Conflicting Claims Between Label and Advertising
Labels and advertisements must be consistent across all promotional channels.
Claim Substantiation Services Offered by BioAgile
CROs like BioAgile Therapeutics provide end-to-end support for claim substantiation, including study design, clinical trials, and Claim Support Dossier preparation.
Literature Review and Evidence Gap Analysis
Systematic reviews identify existing evidence and gaps, determining whether new studies are required.
Clinical Study Design and Conduct
BioAgile designs and conducts clinical studies, including RCTs, ethics approvals, and site management.
Regulatory Dossier Preparation and Submission Support
We prepare compliant dossiers, manage submissions, and support regulator interactions.
Why Choose BioAgile Therapeutics for Label Claims Substantiation
BioAgile Therapeutics combines regulatory expertise, clinical research experience, and bioanalytical capabilities to provide end-to-end support.
Our India-based CDSCO-regulated facility enables cost-effective execution and strong regulatory relationships.
With a proven track record across food, nutraceutical, cosmetic, and pharmaceutical categories, we deliver credible, science-backed claims.
Frequently Asked Questions on Label Claims Substantiation
What does label claim mean?
What are the different types of label claims?
What are the three types of label claims?
What is the purpose of a claim on a product label?
What is claim substantiation?
What is substantiation testing?
How can you assess claims on food labels?
Who approves health claims on food labels?
What is substantiation for dietary supplement claims?
Trusted By
















Contact BioAgile For Label Claim Substantiation Services
Ensure your product claims are compliant, credible, and trusted by consumers.
Contact BioAgile Therapeutics to request a claim substantiation audit, discuss your evidence strategy, or explore clinical study options.
Reach us via email, phone, contact form, or WhatsApp for personalized support and guidance.
Why Choose Us?
Partner with BioAgile today!
Business Address
Contact With Us
Call Us : 080 4375 4520